vs
HOPE BANCORP INC（HOPE）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是HOPE BANCORP INC的1.4倍（$197.9M vs $141.0M），HOPE BANCORP INC净利率更高（20.9% vs 6.7%，领先14.2%），HOPE BANCORP INC同比增速更快（21.0% vs 13.6%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.8%）
希望银行（Bank of Hope）是总部位于美国洛杉矶的银行机构，前身为1980年12月30日成立的威尔希尔银行，核心服务群体为韩裔美国人社区，在当地族裔金融服务领域拥有长期的运营经验。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
HOPE vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$141.0M
营收增速更快
HOPE
高出7.4%
13.6%
净利率更高
HOPE
高出14.2%
6.7%
两年增速更快
RGEN
近两年复合增速
9.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $141.0M | $197.9M |
| 净利润 | $29.5M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 20.9% | 6.7% |
| 营收同比 | 21.0% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.23 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HOPERGEN
| Q1 26 | $141.0M | — | ||
| Q4 25 | $145.8M | $197.9M | ||
| Q3 25 | $141.9M | $188.8M | ||
| Q2 25 | $94.5M | $182.4M | ||
| Q1 25 | $116.5M | $169.2M | ||
| Q4 24 | $118.0M | $174.1M | ||
| Q3 24 | $116.6M | $154.9M | ||
| Q2 24 | $116.9M | $154.1M |
净利润HOPERGEN
| Q1 26 | $29.5M | — | ||
| Q4 25 | — | $13.3M | ||
| Q3 25 | $30.8M | $14.9M | ||
| Q2 25 | $-24.8M | $14.9M | ||
| Q1 25 | $21.1M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $24.2M | $-654.0K | ||
| Q2 24 | $25.3M | $3.3M |
毛利率HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | 26.8% | 9.0% | ||
| Q3 25 | 25.6% | 8.9% | ||
| Q2 25 | -27.6% | 7.6% | ||
| Q1 25 | 23.9% | 3.9% | ||
| Q4 24 | 25.8% | -17.7% | ||
| Q3 24 | 27.5% | -5.1% | ||
| Q2 24 | 29.5% | 1.0% |
净利率HOPERGEN
| Q1 26 | 20.9% | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | 21.7% | 7.9% | ||
| Q2 25 | -26.2% | 8.2% | ||
| Q1 25 | 18.1% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 20.7% | -0.4% | ||
| Q2 24 | 21.6% | 2.2% |
每股收益（稀释后）HOPERGEN
| Q1 26 | $0.23 | — | ||
| Q4 25 | $0.27 | $0.24 | ||
| Q3 25 | $0.24 | $0.26 | ||
| Q2 25 | $-0.19 | $0.26 | ||
| Q1 25 | $0.17 | $0.10 | ||
| Q4 24 | $0.20 | $-0.55 | ||
| Q3 24 | $0.20 | $-0.01 | ||
| Q2 24 | $0.21 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $2.3B | $2.1B |
| 总资产 | $18.7B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益HOPERGEN
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | $2.1B | ||
| Q3 25 | $2.3B | $2.1B | ||
| Q2 25 | $2.2B | $2.1B | ||
| Q1 25 | $2.2B | $2.0B | ||
| Q4 24 | $2.1B | $2.0B | ||
| Q3 24 | $2.2B | $2.0B | ||
| Q2 24 | $2.1B | $2.0B |
总资产HOPERGEN
| Q1 26 | $18.7B | — | ||
| Q4 25 | $18.5B | $2.9B | ||
| Q3 25 | $18.5B | $2.9B | ||
| Q2 25 | $18.5B | $2.9B | ||
| Q1 25 | $17.1B | $2.9B | ||
| Q4 24 | $17.1B | $2.8B | ||
| Q3 24 | $17.4B | $2.8B | ||
| Q2 24 | $17.4B | $2.9B |
负债/权益比HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | $164.5M | $25.7M | ||
| Q3 25 | $51.7M | $48.1M | ||
| Q2 25 | $9.4M | $28.6M | ||
| Q1 25 | $26.7M | $15.0M | ||
| Q4 24 | $116.7M | $39.2M | ||
| Q3 24 | $63.0M | $49.3M | ||
| Q2 24 | $-25.6M | $42.2M |
自由现金流HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | $151.5M | $17.6M | ||
| Q3 25 | $47.2M | $43.4M | ||
| Q2 25 | $6.9M | $21.5M | ||
| Q1 25 | $24.0M | $11.4M | ||
| Q4 24 | $106.9M | $33.6M | ||
| Q3 24 | $60.1M | $42.3M | ||
| Q2 24 | $-28.1M | $37.4M |
自由现金流率HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | 103.9% | 8.9% | ||
| Q3 25 | 33.2% | 23.0% | ||
| Q2 25 | 7.3% | 11.8% | ||
| Q1 25 | 20.6% | 6.8% | ||
| Q4 24 | 90.6% | 19.3% | ||
| Q3 24 | 51.6% | 27.3% | ||
| Q2 24 | -24.0% | 24.3% |
资本支出强度HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | 4.1% | ||
| Q3 25 | 3.2% | 2.5% | ||
| Q2 25 | 2.6% | 3.9% | ||
| Q1 25 | 2.3% | 2.1% | ||
| Q4 24 | 8.3% | 3.2% | ||
| Q3 24 | 2.5% | 4.5% | ||
| Q2 24 | 2.2% | 3.1% |
现金转化率HOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.68× | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | 1.26× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.61× | — | ||
| Q2 24 | -1.01× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
